PAG
DNA icon

Private Advisor Group’s Ginkgo Bioworks DNA Stock Holding History

Private Advisor Group’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-770
Closed -$10.3K – 2444
2024
Q2 		$10.3K Buy
770
+89
+13% +$2.65K ﹤0.01% 2316
2024
Q1 		$31.6K Buy
681
+233
+52% +$12.1K ﹤0.01% 2258
2023
Q4 		$30.3K Buy
448
+151
+51% +$9.25K ﹤0.01% 2177
2023
Q3 		$21.5K Sell
297
-183
-38% -$14.6K ﹤0.01% 2102
2023
Q2 		$35.7K Hold
480
– – ﹤0.01% 1982
2023
Q1 		$25.5K Buy
480
+115
+32% +$7.29K ﹤0.01% 1925
2022
Q4 		$25 Buy
+365
New +$33.6K ﹤0.01% 1638
2022
Q3 		– Sell
-468
Closed -$44K – 1971
2022
Q2 		$44K Buy
+468
New +$57.1K ﹤0.01% 2021

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Private Advisor Group's DNA Position: Q3 2024 in Review

Private Advisor Group sold out of Ginkgo Bioworks (DNA) in Q3 2024, closing a stake of 770 shares — an estimated $10.3K sold.

Private Advisor Group first reported a position in DNA in Q2 2022 and held it in 8 quarters. The position peaked at $44K in Q2 2022. 159 funds tracked by Wall St. Rank hold DNA as of Q3 2024.

  • Private Advisor Group reported no remaining Ginkgo Bioworks position as of Q3 2024 after selling out during the quarter.
  • Private Advisor Group sold 770 Ginkgo Bioworks shares in Q3 2024, an estimated $10.3K.
  • Private Advisor Group first reported a position in Ginkgo Bioworks in Q2 2022 and held it in 8 quarters.
  • Private Advisor Group's Ginkgo Bioworks position peaked at $44K in Q2 2022.
  • 159 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2024.

Based on Private Advisor Group's 13F filing for Q3 2024, filed 22 Oct 2024.